United States:
FDA Announces Renewal Of Nonprescription Drugs Advisory Committee
24 September 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the September 3, 2015, Federal Register, FDA
announced the renewal of the Nonprescription Drugs Advisory
Committee by the FDA Commissioner. The committee is being renewed
for an additional two years beyond the charter expiration date.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...